The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.
- DOI
- 10.1080/17425255.2024.2433626
- Published
- 2025 Jan 21
- Container
- Expert opinion on drug metabolism & toxicology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17425255.2024.2433626,
title = {The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.},
author = {Cacabelos R and Martínez-Iglesias O and Cacabelos N and Carrera J and Rodríguez D and Naidoo V},
year = {2025},
journal = {Expert opinion on drug metabolism \& toxicology},
doi = {10.1080/17425255.2024.2433626},
url = {https://doi.org/10.1080/17425255.2024.2433626}
}RIS
TY - JOUR TI - The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress. AU - Cacabelos R AU - Martínez-Iglesias O AU - Cacabelos N AU - Carrera J AU - Rodríguez D AU - Naidoo V PY - 2025 JO - Expert opinion on drug metabolism & toxicology DO - 10.1080/17425255.2024.2433626 UR - https://doi.org/10.1080/17425255.2024.2433626 ER -
APA
R, C., O, M., N, C., J, C., D, R., & V, N. (2025). The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.. Expert opinion on drug metabolism & toxicology. https://doi.org/10.1080/17425255.2024.2433626
Source records
- pubmed · retrieved 2026-09-26T10:13:42.576Z